These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9559306)

  • 1. [Secondary dermatologic effects of serotonin reuptake inhibitor antidepressants: hypothesis of cross-reacting allergy. Apropos of 2 cases].
    Beauquier B; Fahs H
    Encephale; 1998; 24(1):62-4. PubMed ID: 9559306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical overview of serotonin reuptake inhibitors.
    Rickels K; Schweizer E
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():9-12. PubMed ID: 2147922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New antidepressive agents].
    LaBranche S
    Union Med Can; 1995 Nov; 124(3):8-13. PubMed ID: 8560639
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of the selective serotonin reuptake inhibitors.
    DeVane CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():13-20. PubMed ID: 1531816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
    Tulloch IF; Johnson AM
    J Clin Psychiatry; 1992 Feb; 53 Suppl():7-12. PubMed ID: 1531829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex movement disorders induced by fluoxetine.
    Bharucha KJ; Sethi KD
    Mov Disord; 1996 May; 11(3):324-6. PubMed ID: 8723152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse effects after switching to a different generic form of paroxetine: paroxetine mesylate instead of paroxetine HCl hemihydrate].
    Vergouwen AC; Bakker A
    Ned Tijdschr Geneeskd; 2002 Apr; 146(17):811-2. PubMed ID: 12014241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous adverse effects during selective serotonin reuptake inhibitors therapy: 2 cases].
    Richard MA; Fiszenson F; Jreissati M; Jean Pastor MJ; Grob JJ
    Ann Dermatol Venereol; 2001; 128(6-7):759-61. PubMed ID: 11460042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pattern of usage of new antidepressants in clinical practice].
    Montejo AL; Gilaberte I; Fombellida C; Hylan TR; Sacristán JA
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(2):75-81. PubMed ID: 9595820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SIADH with epileptic seizures and coma in fluoxetine therapy].
    Romerio SC; Radanowicz V; Schlienger RG
    Praxis (Bern 1994); 2000 Mar; 89(10):404-10. PubMed ID: 10731855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse cutaneous reactions associated with fluoxetine strategy for reintroduction of this drug in selected patients.
    Leznoff A; Binkley KE; Joffee RT; Levitt A; Richter MA
    J Clin Psychopharmacol; 1992 Oct; 12(5):355-7. PubMed ID: 1479054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of allergic cross reaction between tricyclic antidepressants and maprotiline].
    Shimizu K; Watanabe M; Kodama Y; Nomura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Aug; 18(4):129-32. PubMed ID: 9866828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe hyponatremia during treatment with fluoxetine].
    Miranda M; Armijo G; Miranda P
    Rev Med Chil; 1999 Mar; 127(3):337-40. PubMed ID: 10436720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies.
    Mackay FJ; Dunn NR; Wilton LV; Pearce GL; Freemantle SN; Mann RD
    Pharmacoepidemiol Drug Saf; 1997 Jul; 6(4):235-46. PubMed ID: 15073774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
    Montejo-González AL; Llorca G; Izquierdo JA; Ledesma A; Bousoño M; Calcedo A; Carrasco JL; Ciudad J; Daniel E; De la Gandara J; Derecho J; Franco M; Gomez MJ; Macias JA; Martin T; Perez V; Sanchez JM; Sanchez S; Vicens E
    J Sex Marital Ther; 1997; 23(3):176-94. PubMed ID: 9292833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of serotonin reuptake inhibitors in the treatment of depressive illness.
    Burrows GD; McIntyre IM; Judd FK; Norman TR
    J Clin Psychiatry; 1988 Aug; 49 Suppl():18-22. PubMed ID: 3045107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.